RA Capital Management - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 18 filers reported holding AKARI THERAPEUTICS PLC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
RA Capital Management ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q4 2016$714,000
-26.4%
101,439
-11.0%
0.10%
+1.0%
Q3 2016$970,000
-69.3%
114,039
-51.3%
0.10%
-77.2%
Q2 2016$3,160,000
+21.6%
234,240
-9.1%
0.44%
+31.9%
Q1 2016$2,598,000
-32.1%
257,721
-2.3%
0.33%
-12.4%
Q4 2015$3,827,000
-39.6%
263,9210.0%0.38%
-58.4%
Q3 2015$6,333,000263,9210.91%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q4 2016
NameSharesValueWeighting ↓
VHCP Management II, LLC 426,297$1,965,0000.78%
Vivo Capital, LLC 527,842$2,433,0000.61%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 818,158$3,772,0000.20%
NEA Management Company, LLC 452,167$2,084,0000.08%
Hikari Power Ltd 60,012$277,0000.04%
Baker Brothers Advisors 496,901$2,291,0000.02%
QVT Financial LP 132,077$531,0000.01%
MILLENNIUM MANAGEMENT LLC 214,126$987,0000.00%
Virtu KCG Holdings LLC 12,472$57,0000.00%
Advisor Group, Inc. 6,381$29,0000.00%
View complete list of AKARI THERAPEUTICS PLC shareholders